Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study

Alsaadi, Taoufik; Hammasi, Khadija El; Shahrour, Tarek M.; Shakra, Mustafa; Turkawi, Lamya; Mudhafar, Abdulla; Diab, Lina; Raoof, Mufeed

doi:10.1155/2015/487159

Cited by 29 publications

(39 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our study, the highest levels of depression, stress, and anxiety were observed in married patients, which is in line with the results of Alsadi et al(2015) [20]. However, Barzegar et al (2017) found no significant association between marital status and depression among MS patients in Iran [22].…”

Section: Discussionsupporting

confidence: 92%

“…The results of our study and those of the above study were similar with respect to the prevalence of anxiety and depression. The results of the study by Alsaadi et al (2015) in Emirates showed from 80 MS patients, 17% had severe depression and 20% had moderate Anxiety. Moreover, no significant relationship was found between anxiety and depression and variables age, sex, and education [20].…”

Section: Discussionmentioning

confidence: 97%

“…The results of the study by Alsaadi et al (2015) in Emirates showed from 80 MS patients, 17% had severe depression and 20% had moderate Anxiety. Moreover, no significant relationship was found between anxiety and depression and variables age, sex, and education [20]. Regarding the relatively high prevalence of anxiety and depression in the MS patients, our results were in line with those of the above study.…”

Section: Discussionmentioning

confidence: 97%

See 2 more Smart Citations

Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study

2020

View full text Add to dashboard Cite

Background: Multiple sclerosis (MS) is a chronic disease that decreases the physical ability and affects the mental health of the patients. This descriptive-analytical study investigated the prevalence of depression, anxiety and stress in MS patients. Methods: A total of 87 MS patients were recruited in this study through simple random sampling method using a random number table. Data were collected by Depression, Anxiety, and Stress Scale-21 (DASS-21) and analyzed by descriptive and analytical statistics. Results: The mean age of the patients was 35.5 ± 9.2 years. Of them, 41 (47.1%) had moderate depression, 34 (39.1%) had moderate anxiety, and 39 (44.8%) had moderate stress. There was a significant relationship between depression and job, education, and economic status of the participants. There was also a significant association between the participants' economic status and anxiety. There was no significant relationship between stress and any of the variables. Conclusion: Given the relatively high prevalence of anxiety, depression, and stress in MS patients as well as the significant relationship between their economic status and depression and anxiety, interventional measures are required to be taken to decrease their problems and to provide a favorable ground for their employment. Periodic examinations by psychologists / psychiatrists and treatment of patients with symptoms of stress, anxiety and depression are also essential.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 97%

Section: Discussionmentioning

confidence: 97%

See 1 more Smart Citation

Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study

2020

View full text Add to dashboard Cite

show abstract

“…Only one pilot study has been conducted on the link between depression and MS in the UAE. 15 However, that study did not find an increased rate of depression, unlike several studies in other Arab countries, 15,16 possibly due to the small sample size and single-center nature of the study. The present study aimed to examine these findings in a multicenter study with a larger sample size and explore the differences in depression as a function of demographic variables and disease characteristics.…”

Section: Patient Characteristicscontrasting

confidence: 55%

Multiple Sclerosis, Anxiety, and Depression in the United Arab Emirates

Schiess¹,

Huether²,

Holroyd³

et al. 2019

International Journal of MS Care

Self Cite

View full text Add to dashboard Cite

Background: Depression rates in the multiple sclerosis (MS) population in the Arab world have rarely been reported despite people with MS generally having higher rates of depression. We examined depression rates in 416 people with MS versus the general population of Abu Dhabi, United Arab Emirates, and their treatment. Methods: A retrospective medical record review of 416 people with MS (age range, 16–80 years) followed up at four large government hospitals in Abu Dhabi was conducted to determine the percentage of people with MS diagnosed as having depression or anxiety. Results: The depression rate in people with MS (10.8%) was close to that in the general population of Abu Dhabi. The adjusted odds ratios of depression by selected variables showed that there was a significant difference (P = .003) between females and males in reporting depression, with more females reporting depression than males. Greater MS duration was also associated with a higher likelihood of being depressed (P = .025). The anxiety rate in the cohort (4.8%) was lower than that in the general Abu Dhabi population (18.7%). Conclusions: The depression rate in people with MS in Abu Dhabi was close to that of the general Abu Dhabi population, but the anxiety rate in people with MS was lower. Explanations for these low rates include possible underreporting by patients and physician factors such as time limitations in busy clinics. Cultural aspects such as strong family support systems and religious factors in this predominantly Muslim population are also possible factors that warrant further investigation.

show abstract

“…The very moment of receiving the diagnosis is a stressful, life-changing event for the majority of patients and their families. To improve the quality of life of the patients, recognition of this emotional and cognitive burden is crucial in regards to all parties involved (7) (8).…”

Section: Introductionmentioning

confidence: 99%

Prevalence of psychiatric disorders among patients with Multiple Sclerosis: a cross-sectional study.

Błachut¹,

Szczegielniak

Świerzy

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Multiple Sclerosis is one of the leading autoimmune disorders causing disability among young adults. Various types of mood, affect, and behaviour disorders along with cognitive impairment can be manifested in a course of MS, with affective and anxiety disorders being the most prevalent. Mental health challenges, in addition to the neurological burden of MS, significantly affect quality of life and the course of the underlying disease. Objective: The aim of this work was to determine the prevalence of mental disorders in a sample of MS patients during outpatient treatment in Zabrze, Poland, with a focus on those with mood and anxiety disorders, and to compare the results obtained in these groups with clinical and sociodemographic data. Method: The study was conducted between 2017 and 2018 on 103 MS patients of the Neurological Outpatient Clinic of the Medical University of Silesia Hospital No.1 in Zabrze, Poland. During the study, sociodemographic data were collected, as well as the type and course of the underlying disease, comorbidities, and medicines used. The MINI-international neuropsychiatric interview and a psychiatric examination were utilized to assess the occurrence of mental disorders. Result: 68% of all patients received a psychiatric diagnosis at some point in their life with only 4% having been hospitalized before; 49.5% met the diagnostic criteria for various psychiatric disorders. Measured by the MINI International Neuropsychiatric Interview, 33% of patients reported a past episode of major depression while 8.7% met the criteria for a current episode. The same number of patients admitted ongoing treatment due to recurrent depressive disorder. In regards to anxiety disorders, the most common was generalized anxiety disorder (10.7%), followed by agoraphobia (8.7%), panic disorder (7.8%), and social phobia (4.9%). Most of the patients (94.2%) at the time of the psychiatric evaluation presented a low level of suicide risk, while 1.9% of the patients presented a medium risk, and 3.9% - a high risk. Conclusion(s): The study confirmed a significantly higher prevalence of mental disorders among MS patients; thus, the psychiatric state of patients in this group should be investigated systematically, simultaneously with the assessment of their neurological state. Trial registration: N/A Key words: Multiple Sclerosis, psychiatric disorders, comorbidity, psychiatric care, clinical characteristics.

show abstract

Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study

Cited by 29 publications

References 27 publications

Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study

Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study

Multiple Sclerosis, Anxiety, and Depression in the United Arab Emirates

Prevalence of psychiatric disorders among patients with Multiple Sclerosis: a cross-sectional study.

Contact Info

Product

Resources

About